News in brief: TGA safety warning on dienogest; #38mate campaign for myeloma; Hospital doctors bullied to discharge patients early

Dienogest adds modest VTE risk to COC  A Medicines Safety Update from the TGA has clarified the risk of VTE in women using combined oral contraceptives (COC) containing dienogest. The Update said the risk of VTE in women taking dienogest/ethinylestradiol was estimated to be 8–11/10,000 per year compared to 5–7/10,000 for women taking levonorgestrel/ethinylestradiol. The ...

Already a member?

Login to keep reading.

© 2021 the limbic